- Exchange: New York
- Sector: Health Care
- Industry: Medical Equipment/Devices
- Sub-Industry: Cardiovascular Devices
Edwards Lifesciences Corp
+ Add to WatchlistEW:US
70.4800 USD 0.4800 0.69%As of 20:04:08 ET on 06/17/2013.
Snapshot for Edwards Lifesciences Corp (EW)
| Open: | 70.3800 | Day's Range: | 70.0800 - 70.6800 | Volume: | 814,585 |
|---|---|---|---|---|---|
| Previous Close: | 70.0000 | 52wk Range: | 62.3400 - 110.7900 | 1-Yr Rtn: | -29.98% |
Key Statistics for EW
| Current P/E Ratio (ttm) | 24.1290 |
|---|---|
| Estimated P/E(12/2013) | 23.0855 |
| Relative P/E vs. SPX | 1.5072 |
| Earnings Per Share (USD) (ttm) | 2.9210 |
| Est. EPS (USD) (12/2013) | 3.0530 |
| Est. PEG Ratio | 1.3456 |
| Market Cap (M USD) | 7,961.54 |
| Shares Outstanding (M) | 112.96 |
| 30 Day Average Volume | 1,510,351 |
| Price/Book (mrq) | 5.0248 |
| Price/Sale (ttm) | 4.1788 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/25/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for EW
Company Profile & Key Executives for EW
Edwards Lifesciences Corporation designs, develops, manufactures, and markets products and services to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards supplies its products to customers located worldwide.
| Michael A MussallemChairman/CEO | Thomas M Abate "Tom"VP/CFO |
| Aimee S WeisnerVP/General Counsel | Carlyn D SolomonVP:Critical Care & Vascular |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
EW News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page